Pre-orders worth a potential value of over $2.5 million USD
Organizations Involved
Y Combinator, StartX
Founders
Liza Velarde, Alejandro Abarca, Juan Felipe Yee
Company Description
At Delee, they have created the CytoCatch™️ isolation platform and imaging system for early cancer detection and monitoring the effectiveness of applied treatments. Their technology enables the performance of a CTC blood-based assay, potentially revolutionizing cancer diagnosis and treatment optimization.